Literature DB >> 34484960

Antiglutamic Acid Decarboxylase 65 Antibody-Associated Hemiataxia.

Emily J Hill1, Joseph Jankovic1.   

Abstract

Entities:  

Year:  2021        PMID： 34484960      PMCID： PMC8382435          DOI： 10.1212/CPJ.0000000000000939

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  6 in total

Review 1.  Autoimmune and paraneoplastic movement disorders: An update.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2017-12-30       Impact factor: 3.181

2.  Rapidly Progressive Cerebellar Hemiataxia with High Levels of GAD65 Reactive Antibodies.

Authors:  Wietse Wiels; Francois Guisset; Fenne Vandervorst; Ilse Peeters; Laura Seynaeve; Olivier Costa; Anja Flamez; Jacques De Keyser
Journal:  Mov Disord Clin Pract       Date:  2017-06-01

3.  Clinical Reasoning: A 70-year-old woman with acute-onset weakness and progressive hemiataxia.

Authors:  Karisa C Schreck; Jennifer L Orthmann-Murphy; Scott D Newsome
Journal:  Neurology       Date:  2016-11-29       Impact factor: 9.910

Review 4.  Stiff-person syndrome: insights into a complex autoimmune disorder.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-12-15       Impact factor: 10.154

5.  Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.

Authors:  Amaia Muñoz-Lopetegi; Marienke A A M de Bruijn; Sanae Boukhrissi; Anna E M Bastiaansen; Mariska M P Nagtzaam; Esther S P Hulsenboom; Agnita J W Boon; Rinze F Neuteboom; Juna M de Vries; Peter A E Sillevis Smitt; Marco W J Schreurs; Maarten J Titulaer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-02

6.  Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?

Authors:  Mario Manto; Hiroshi Mitoma; Christiane S Hampe
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.